Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00225056
Status:
TERMINATED
Last Update Posted:
2007-04-20
First Post:
2005-09-21
Brief Title:
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
Sponsor:
Oncology Specialties Alabama
Organization:
Oncology Specialties Alabama
Organization Data
Organization:
Oncology Specialties Alabama
Class:
OTHER
Study ID:
CCIBRE02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncology Specialties Alabama
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None